Pharmacokinetics of ginsenoside Rb1 and its metabolite compound K after oral administration of Korean Red Ginseng extract
Open Access
- 15 October 2013
- journal article
- Published by Elsevier BV in Journal of Ginseng Research
- Vol. 37 (4), 451-456
- https://doi.org/10.5142/jgr.2013.37.451
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Development and validation of an LC-MS/MS method for determination of compound K in human plasma and clinical applicationJournal of Ginseng Research, 2013
- Ginsenoside compound K, not Rb1, possesses potential chemopreventive activities in human colorectal cancerInternational Journal of Oncology, 2012
- Pharmacokinetics of a ginseng saponin metabolite compound K in ratsBiopharmaceutics & Drug Disposition, 2005
- DEGRADATION OF GINSENOSIDES IN HUMANS AFTER ORAL ADMINISTRATIONDrug Metabolism and Disposition, 2003
- Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatinCancer Letters, 1999
- Antimetastatic Efficacy of Orally Administered Ginsenoside Rb1in Dependence on Intestinal Bacterial Hydrolyzing Potential and Significance of Treatment with an Active Bacterial MetabolitePlanta Medica, 1998
- Drug Metabolism: Intestinal Bacterial Hydrolysis is Required for the Appearance of Compound K in Rat Plasma after Oral Administration of Ginsenoside Rb1 from Panax ginsengJournal of Pharmacy and Pharmacology, 1998
- An Intestinal Bacterial Metabolite of Ginseng Protopanaxadiol Saponins Has the Ability to Induce Apoptosis in Tumor CellsBiochemical and Biophysical Research Communications, 1998
- Role of Human IntestinalPrevotella orisin Hydrolyzing Ginseng SaponinsPlanta Medica, 1997
- Studies on absorption, distribution, excretion and metabolism of ginseng saponins. V. The decomposition products of ginsenoside Rb2 in the large intestine of rats.CHEMICAL & PHARMACEUTICAL BULLETIN, 1990